Catalysts for $ABBV
477 tracked
Oct 7, 2011
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Sep 7, 2011
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Jul 13, 2011
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Mar 14, 2011
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Feb 25, 2011
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Nov 18, 2010
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Sep 29, 2010
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Sep 24, 2010
approval
OZURDEX (DEXAMETHASONE) — FDA approval
dexamethasone LA
→
Aug 31, 2010
approval
OZURDEX (DEXAMETHASONE) — FDA approval
dexamethasone LA
→
Jul 29, 2010
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Apr 8, 2010
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Jun 17, 2009
approval
OZURDEX (DEXAMETHASONE) — FDA approval
dexamethasone LA
→
Apr 23, 2009
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Apr 23, 2009
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Apr 23, 2009
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 11, 2009
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Mar 24, 2008
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Mar 24, 2008
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Feb 21, 2008
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Jan 18, 2008
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Oct 30, 2007
approval
COMBIGAN (BRIMONIDINE TARTRATE) — FDA approval
Lumify
→
Sep 5, 2007
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Jul 30, 2007
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Feb 27, 2007
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Feb 16, 2007
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Dec 19, 2006
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 9, 2006
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Nov 9, 2006
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Oct 13, 2006
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Oct 13, 2006
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→